fbpx

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

Lund, Sweden, 12:00 pm CET, 30 December 2019 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today announced a change in the number of shares and votestoday announced the publication of the Level I clinical study CERTiFy in the highly ranked Journal of Bone and Joint Surgerytoday announced the publication of the Level I clinical study CERTiFy in the highly ranked Journal of Bone and Joint Surgery. During December, the number of shares and votes in BONESUPPORT HOLDING AB (publ) has increased with 60,000 due to the exercise of warrants. As of 31 December 2019, the number of shares in BONESUPPORT HOLDING AB (publ) amounts to 52,521,342 shares, of which 52,016,342 are ordinary shares with one vote per share and 505,000 are series C shares with one-tenth of a vote per share. The number of votes in the company amounts to 52,066,842 votes.

About BONESUPPORT™

BONESUPPORT™ (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver and a Premarket approval filing with the FDA (USA) for CERAMENT G is planned in 2021. The company is based in Lund, Sweden, and the net sales amounted to SEK 97 million in 2018. Please visit www.bonesupport.com for more information.

BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.
For more information contact:

BONESUPPORT AB
Emil Billbäck, CEO
+46 (0) 46 286 53 70

Håkan Johansson, CFO
+46 (0) 46 286 53 70
ir@bonesupport.com

Cord Communications
Charlotte Stjerngren
+46 (0) 708 76 87 87
charlotte.stjerngren@cordcom.se
www.cordcom.se

Nyheder

Vil undersøge evt. sammenhæng mellem hovedpinepiller og tidlige ufrivillige aborter
6. januar 2020
Kræftpatienter donerer levende hjerneceller til forskere
17. december 2019
Lundbeckfonden giver 60 mio. kr. til dristige videnskabelige ideer
11. december 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge